Witte ON - Search Results

1

Genetic approaches to defining signaling by the CML-associated tyrosine kinase BCR-ABL.

Afar DE, Goga A, Cohen L, Sawyers CL, McLaughlin J, Mohr RN, Witte ON. Afar DE, et al. Among authors: witte on. Cold Spring Harb Symp Quant Biol. 1994;59:589-94. doi: 10.1101/sqb.1994.059.01.067. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587117 Review. No abstract available.

2

Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro.

Gishizky ML, Witte ON. Gishizky ML, et al. Among authors: witte on. Science. 1992 May 8;256(5058):836-9. doi: 10.1126/science.1375394. Science. 1992. PMID: 1375394

3

A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.

Muller AJ, Pendergast AM, Havlik MH, Puil L, Pawson T, Witte ON. Muller AJ, et al. Among authors: witte on. Mol Cell Biol. 1992 Nov;12(11):5087-93. doi: 10.1128/mcb.12.11.5087-5093.1992. Mol Cell Biol. 1992. PMID: 1383690 Free PMC article.

4

Dominant negative MYC blocks transformation by ABL oncogenes.

Sawyers CL, Callahan W, Witte ON. Sawyers CL, et al. Among authors: witte on. Cell. 1992 Sep 18;70(6):901-10. doi: 10.1016/0092-8674(92)90241-4. Cell. 1992. PMID: 1525828

5

Propagation of human blastic myeloid leukemias in the SCID mouse.

Sawyers CL, Gishizky ML, Quan S, Golde DW, Witte ON. Sawyers CL, et al. Among authors: witte on. Blood. 1992 Apr 15;79(8):2089-98. Blood. 1992. PMID: 1562735 Free article.

6

Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.

Pendergast AM, Muller AJ, Havlik MH, Clark R, McCormick F, Witte ON. Pendergast AM, et al. Among authors: witte on. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5927-31. doi: 10.1073/pnas.88.13.5927. Proc Natl Acad Sci U S A. 1991. PMID: 1712111 Free PMC article.

7

BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.

Pendergast AM, Muller AJ, Havlik MH, Maru Y, Witte ON. Pendergast AM, et al. Among authors: witte on. Cell. 1991 Jul 12;66(1):161-71. doi: 10.1016/0092-8674(91)90148-r. Cell. 1991. PMID: 1712671

8

Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.

Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N. Kelliher M, et al. Among authors: witte on. Mol Cell Biol. 1991 Sep;11(9):4710-6. doi: 10.1128/mcb.11.9.4710-4716.1991. Mol Cell Biol. 1991. PMID: 1875948 Free PMC article.

9

The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cells.

Gishizky ML, McLaughlin J, Pendergast AM, Witte ON. Gishizky ML, et al. Among authors: witte on. Oncogene. 1991 Aug;6(8):1299-306. Oncogene. 1991. PMID: 1886706

10

Significance of residual leukaemia transcripts after bone marrow transplant for CML.

Hughes T, Martiat P, Morgan G, Sawyers C, Witte ON, Goldman ON. Hughes T, et al. Among authors: witte on. Lancet. 1990 Jan 6;335(8680):50. doi: 10.1016/0140-6736(90)90175-5. Lancet. 1990. PMID: 1967352 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters